Author Question: A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a ... (Read 100 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a (Pegasys), ribavirin (Ribasphere), and boceprevir (Victrelis). The patient tells the nurse that his wife is pregnant. What will the nurse tell him?
 
  a. Boceprevir is contraindicated in males whose partners are pregnant.
  b. He should use a barrier contraceptive when having sex.
  c. He should use dual drug therapy with pegylated interferon alfa and ribavirin only.
  d. This combination drug therapy is safe for him to use.

Question 2

A patient has a positive test for hepatitis C and is admitted to the hospital. The admission laboratory tests reveal a normal ALT, and a liver biopsy is negative for hepatic fibrosis and inflammation. The nurse will prepare this patient for:
 
  a. dual therapy with pegylated interferon alfa and ribavirin.
  b. no medication therapy at this time.
  c. pegylated interferon alfa only until ALT levels are elevated.
  d. triple drug therapy with pegylated interferon alfa, ribavirin, and boceprevir.



Jossy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

ANS: A
The triple combination is dangerous for pregnant women whose partners are using it, so it is contraindicated for any man whose partner is pregnant. Barrier contraceptives should be used by couples when either partner is taking the triple combination therapy to prevent pregnancy. Ribavirin is teratogenic and is not safe when a partner is pregnant. This combination is not safe for pregnant women whose partners are taking these drugs.

Answer to Question 2

ANS: B
Current recommendations are that treatment is used only for patients with HCV viremia, persistent elevation of ALT, and evidence of hepatic fibrosis and inflammation upon liver biopsy. Dual therapy has been the regimen of choice for patients with the above symptoms, but the addition of a protease inhibitor has been shown to improve outcomes. It is not correct to give pegylated interferon alfa until ALT levels are elevated. Triple drug therapy is used for patients with the above symptoms.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Both answers were spot on, thank you once again



Jossy

  • Sr. Member
  • ****
  • Posts: 336

 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

For a complete list of videos, visit our video library